Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Gadodiamide (liposomal)

EU orphan designation number: EU/3/08/583   
Active ingredient: Gadodiamide (liposomal)
Indication: Treatment of glioma
Sponsor: Dr Matthias Luz
Brunhildestraße 46, 68199 Mannheim, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
5/12/2008 Orphan designation EMEA/OD/034/08 (2008)8093 of 3/12/2008